Abstract: The current disclosure provides methods and compositions for treating food allergies, infections, autoimmune conditions, and other allergic conditions. Accordingly, the current disclosure relates to a method for treating an infectious, autoimmune, or allergic disease in a subject comprising administering a composition comprising bacterium Anaerostipes caccae to the subject. Further aspects relate to a method for treating a food allergy or for reducing an allergic response to an allergen or for treating or preventing an anaphylactic response in a subject comprising administering a composition comprising bacterium Anaerostipes caccae and a prebiotic to the subject.
Type:
Application
Filed:
November 5, 2019
Publication date:
December 16, 2021
Applicants:
The University of Chicago, ClostraBio
Inventors:
Cathryn R. NAGLER, Riyue BAO, Dionysios ANTONOPOULOS, John W. COLSON, Lauren Anders HESSER